Although the medication would require a prescription, it will likely be for people with moderate symptoms of Covid-19. Dr Carlos Del Rio, the executive associate dean and a global health expert at the Emory School of Medicine, didn’t hide his excitement, as right now, Covid-19 patients can be only sent home to monitor their symptoms. But having a new and effective pill to offer to these patients would be really life-changing.
For the moment, Merck and Ridgeback announced the results of an ongoing Phase 3 study, which are extremely satisfying. As a matter of fact, they reached such a level of satisfaction, that the FDA, alongside an independent monitoring board, recommended ending the trial early so they can rapidly seek authorization.
Unfortunately for us, Covid-19 won't be giving us a break in 2022 either. The new… Read More
During the winter, doctors have lots of patients that are often sick. They either have… Read More
Although the crisp winter air is a reason for joy for many winter lovers, if… Read More
Certain body parts don't need to be squeaky clean. Although stepping into a warm, steaming… Read More
There are lots of things we still don't understand about the new coronavirus. The virus… Read More
When something is off with our lungs, it will be easier to notice than with… Read More